✦ LIBER ✦

Chemoimmunotherapy of disseminated malignant melanoma with DTIC-BCG, transfer factor + melphalan

✍ Scribed by Max A. Schwarz; Jordan U. Gutterman; Michael A. Burgess; Lance K. Heilbrun; William K. Murphy; Gerald P. Bodey; E. Stone; V. Turner-Chism; Evan M. Hersh

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 960 KB
Volume: 45
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19800515)45:10<2506::aid-cncr2820451007>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant treatment of malignant melanoma

Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG

✍ Dr. Constantine P. Karakousis; Lawrence J. Emrich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

Eighty-two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their surgical treatment to 1) observation; 2) chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year; and 3) immu

Treatment of disseminated malignant mela

Treatment of disseminated malignant melanoma with high-dose oral BCG

✍ Antonio Drauzio Varella; Dino Carlos Bandiera; Antonio R. De Amorim Sr.; Luciano 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Comparison of the combination of 1, 3-bi

Comparison of the combination of 1, 3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-l-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma

✍ John H. Moon; Dr. Salman Gailani; M. Robert Cooper; Donald M. Hayes; Vishram B. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views